Top Medical News
Jairia Dela Cruz, an hour ago
Midazolam nasal spraydelivers prompt and prolonged seizure control with a favourable safety profile in the outpatient treatment of patients experiencing a seizure cluster, according to the results of the phase III ARTEMIS-1* trial.
Roshini Claire Anthony, 2 hours ago

A 2-week course of the immunotherapy drug teplizumab delayed the onset of type 1 diabetes (T1D) in individuals at high risk for the condition, according to a phase II trial conducted by the TrialNet Study Group and presented at ADA 2019.

3 hours ago
Diabetic ketoacidosis (DKA) is more likely to develop in users of sodium glucose cotransporter 2 inhibitor (SGLT2i) than in nonusers, according to a new study, which shows a small but significant association between SGLT2i use and increased risk of DKA.
Stephen Padilla, 4 hours ago
Accelerated cognitive decline is significantly associated with incident coronary heart disease (CHD) after, but not before or immediately following, ischaemic events, suggests a recent study.
5 hours ago
Hypopituitary men with central diabetes insipidus (CDI) have low plasma oxytocin levels and increased psychopathology, which suggests a potential oxytocin deficiency, according to a study.
5 hours ago
Use of oral contraceptive agents in combination with metformin or lifestyle changes appears to effectively reduce the adverse impact of polycystic ovary syndrome (PCOS) on glucose and lipid metabolism in overweight women, according to the results of a network meta-analysis.
Audrey Abella, 6 hours ago
Vaccination in children undergoing immunosuppressive therapy for rheumatic disease (RD) did not lead to further infections nor cause disease flares, thereby highlighting the safety of both live-attenuated and inactive vaccines in this population, according to data presented at EULAR 2019.
Special Reports
19 Jun 2019
At a recent Boehringer Ingelheim-sponsored symposium held in conjunction with the National Heart Association of Malaysia Congress 2019, two distinguished speakers discussed the importance of cardiovascular (CV) risk management in patients with type 2 diabetes mellitus (T2DM), and highlighted the role of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in reducing the risk of adverse CV outcomes.
19 Jun 2019
Acquired immunodeficiency syndrome (AIDS) remains as one of the world’s leading causes of mortality in global public health. Dr Charles Hicks shared his insights into the increasing role of dolutegravir (DTG; Tivicay, GSK) – an integrase strand transfer inhibitor (INSTI) – in HIV therapy during the 4th National AIDS Conference 2018 at Swiss Garden International Hotel and Residences, Kuala Lumpur.
12 Jun 2019
Urogenital infections remain a major reason for women to visit their family physician and their subsequent referral to obstetrics and gynaecology or urology specialists. The association between abnormal vaginal microbiota and an increased risk of contracting sexually transmitted diseases (STDs), as well as an increased rate of preterm labour, indicates the need to better understand and manage urogenital health in women. Probiotics are “live microorganisms which, when administered in adequate amounts, confer a health benefit on the host”. As such, there is a sound rationale for using probiotics to maintain female vaginal and bladder health.
12 Jun 2019
In conjunction with TRB Chemedica’s 30th anniversary, a panel of distinguished speakers shared their insights into the management of the associated disorders surrounding dry eye disease (DED) at the HOPE Symposium.
03 Jun 2019
The 17th Congress of Asia Pacific Federation of Coloproctology held at Kuala Lumpur Convention Centre saw many local and international experts speaking on various topics in the field of coloproctology. In a symposium chaired by Dato’ Dr Meheshinder Singh, a panel of experts from France and India discussed the results of the CHORUS study, which investigated the association between haemorrhoidal disease (HD) and chronic venous disease (CVD), as well as the efficacy of micronized purified flavonoid fraction (MPFF) in HD.
03 May 2019
At a Boehringer Ingelheim-sponsored symposium, held in conjunction with the joint 12th International Diabetes Federation Western PacificRegion Congress & 10th Asian Association for the Study of Diabetes Scientific Meeting in Kuala Lumpur, two prominent speakers discussed therapidly evolving treatment landscape for diabetes, focusing on the implications of heart failure (HF) and chronic kidney disease (CKD) in thediabetes continuum.
02 May 2019
At a recent Abbott lunch symposium held in conjunction with the joint 12th International Diabetes FederationWestern Pacific Region Congress & 10th Asian Association for the Study of Diabetes Scientific Meeting in KualaLumpur, Professor Shashank R. Joshi extensively discussed the issue of diabetes in obesity and the role of nutritionalintervention in addressing this growing problem.
Conference Reports
Audrey Abella, 27 Jun 2019
Vaccination in children undergoing immunosuppressive therapy for rheumatic disease (RD) did not lead to further infections nor cause disease flares, thereby highlighting the safety of both live-attenuated and inactive vaccines in this population, according to data presented at EULAR 2019.
Pearl Toh, 26 Jun 2019
Patients with rheumatoid arthritis (RA) who maintained their disease remission had a significantly reduced risk of clinical and subclinical atherosclerosis, according to the 3-year follow-up data of the GIRRCS* study presented at EULAR 2019.
Roshini Claire Anthony, 26 Jun 2019

A treatment combination comprising verinurad and febuxostat could slow chronic kidney disease (CKD) progression by reducing albuminuria and hyperuricaemia in patients with type 2 diabetes (T2D), according to a study presented at EULAR 2019.

Audrey Abella, 26 Jun 2019
The iLet Bionic Pancreas System can effectively control blood glucose levels in adults with type 1 diabetes (T1D), according to data from the first human study of the device presented at ADA 2019.
Elaine Soliven, 26 Jun 2019
Patients with youth-onset type 2 diabetes (T2D) are more likely to have an increased rate of cardiovascular (CV), kidney, eye, nerve, and pregnancy complications as they transition to early adulthood, according to the longest-running TODAY*2 study presented at ADA 2019.
26 Jun 2019
Podcast: Dr Lawrence Leiter expounds on the renal benefits seen with dapagliflozin in DECLARE-TIMI 58
26 Jun 2019
Slideshow: Highlights from the 79th Scientific Sessions of the American Diabetes Association
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download